Mesoblast (MESO) Free Cash Flow Growth (3y) (2019 - 2023)
Mesoblast (MESO) Free Cash Flow Growth (3y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
-8.13% |
| Mar 31, 2023 |
-6.52% |
| Dec 31, 2022 |
131.28% |
| Sep 30, 2022 |
-2.80% |
| Jun 30, 2022 |
-6.84% |
| Mar 31, 2022 |
-9.95% |
| Dec 31, 2021 |
-107.85% |
| Sep 30, 2021 |
-2.35% |
| Jun 30, 2021 |
-12.03% |
| Mar 31, 2021 |
92.20% |
| Dec 31, 2020 |
-36.62% |
| Sep 30, 2020 |
-11.43% |
| Jun 30, 2020 |
-54.96% |
| Mar 31, 2020 |
40.52% |
| Dec 31, 2019 |
27.08% |
| Sep 30, 2019 |
40.05% |
| Jun 30, 2019 |
-74.73% |
